Alkermes
Alkermes is a provider of innovative medicines that address the unmet needs and challenges of people living with debilitating diseases. As a fully integrated global biopharmaceutical company, Alkermes applies its scientific expertise, proprietary technologies, and global resources to develop products that are designed to make a meaningful difference in the way patients manage their disease.
Financial Data
-
31st Dec 17 Source: Company
- €541.4 million turnover
-
-€146.6 million
profit - 2,000 employees
-
31st Dec 16 Source: CRO
- €438 million turnover
-
€147.3 million
profit - 380 employees
- 5 more years available »
Ranking
By Turnover
(€541.4 million)- 142nd in Top Companies
- 20th in Health
- 18th in Pharma
By Employees
(2,000)- 121st in Top Companies
- 20th in Health
- 10th in Pharma
-
- 2,000
- €541.4 million
Employees
- Richard Pops CEO/Managing Director
Latest News
- 7:52am IEA does not expect ‘huge increase’ in crude oil prices
- 7:39am Dollar under pressure after Fed fuels bets on large rate cut
- 7:31am White House planning to send Pelosi list of spending cuts
- 7:22am Boeing to take £3.9bn hit to compensate airlines
- 6:30am Donohoe rejects IFAC criticism, Uniphar’s Nordic plans, and why the truth hurts